Urology

Does systematic biopsy add value to the detection rate of prostate cancer?

Presented By

Dr Enrico Checcucci, University of Turin, Italy

Conference

EAU 2022

Type

News article

22 July 2022 12:42

PSMA PET/CT cannot replace mpMRI for diagnosis of prostate cancer

Presented By

Prof. Lih-Ming Wong, University of Melbourne, Australia

Trial

Phase 3

Conference

EAU 2022

Type

News article

22 July 2022 12:41

Prostate cancer treatments reduce quality of life

Presented By

Mr André Deschamps, Europa Uomo, Belgium

Trial

EUPROMS 2.0

Conference

EAU 2022

Type

News article

22 July 2022 12:39

PROpel: Good results for abiraterone plus olaparib in mCRPC

Presented By

Prof. Noel Clarke, University of Manchester, UK

Trial

Phase 3, PROpel

Conference

EAU 2022

Type

News article

22 July 2022 12:37

Neoadjuvant hormonal therapy promising in high-risk prostate cancer

Presented By

Prof. Steven Joniau, UZ Leuven, Belgium

Trial

Phase 2, ARNEO

Conference

EAU 2022

Type

News article

22 July 2022 12:35

Darolutamide performs well across subgroups in mHSPC

Presented By

Prof. Bertrand Tombal, Université Catholique de Louvain, Belgium

Trial

Phase 3, ARASENS

Conference

EAU 2022

Type

News article

22 July 2022 12:33

Shorter hospital stay with robotic surgery versus open surgery in bladder cancer

Presented By

Prof. James Catto, University of Sheffield, UK

Trial

Phase 3, iROC

Conference

EAU 2022

Type

News article

22 July 2022 12:30

Improved risk stratification for high-risk NMIBC

Presented By

Mr Florus de Jong, Erasmus University Medical Center, the Netherlands

Conference

EAU 2022

Type

News article

22 July 2022 12:28

Adjuvant atezolizumab may benefit ctDNA-positive patients with post-op muscle-invasive urothelial carcinoma

Presented By

Prof. Jürgen Gschwend, Technical University Munich, Germany

Trial

Phase 3, IMvigor010

Conference

EAU 2022

Type

News article

22 July 2022 12:26

New prognostication in N3 penile cancer

Presented By

Dr James Churchill, St George Hospital, Australia

Conference

EAU 2022

Type

News article

22 July 2022 12:24

KEYNOTE-564: Updated results of adjuvant pembrolizumab in RCC

Presented By

Prof. Thomas Powles, Barts Cancer Institute, UK

Trial

Phase 3, KEYNOTE-564

Conference

EAU 2022

Type

News article

22 July 2022 12:22

Fewer complications with robotic surgery in renal cancer

Presented By

Prof. Marc-Oliver Grimm, Universitätsklinikum Jena, Germany

Trial

Phase 3, OpeRa

Conference

EAU 2022

Type

News article

22 July 2022 12:19

Novel therapeutic targets for benign prostatic hyperplasia

Presented By

Prof. Richard Bryant, University of Oxford, UK

Conference

EAU 2022

Type

News article

22 July 2022 12:17

Mini-slings non-inferior to standard mid-urethral slings in SUI

Presented By

Prof. Mohamed Abdel-fattah, University of Aberdeen, UK

Trial

SIMS

Conference

EAU 2022

Type

News article

22 July 2022 12:14

Non-inferiority of methenamine hippurate to antibiotics in recurrent UTIs

Presented By

Prof. Christopher Harding, Newcastle University, UK

Trial

ALTAR

Conference

EAU 2022

Type

News article

22 July 2022 12:02

Letter from the Editor

Editor

Prof. Hendrik Van Poppel, Urology, KU Leuven, Belgium

Conference

EAU 2021

31 August 2021 12:30

EAU TV: The best on bladder cancer and renal cell carcinoma

Presented By

Prof. Arnulf Stenzl

Conference

EAU 2021

31 August 2021 12:29

Best of EAU: Immune cell populations have prognostic value in RCC

Presented By

Dr Alberto Breda, Autonomous University of Barcelona, Spain

Conference

EAU 2021

Type

Peer-reviewed article

31 August 2021 12:28

KEYNOTE-564: First positive phase 3 results with adjuvant checkpoint inhibition in RCC

Presented By

Prof. Thomas Powles, Barts Cancer Centre, London, UK

Trial

Phase 3, KEYNOTE-564

Conference

EAU 2021

Type

Peer-reviewed article

31 August 2021 12:28

PSMA PET-CT more accurate than standard-of-care imaging in RCC

Presented By

Dr Arsalan Tariq , Royal Brisbane and Women's Hospital, Australia

Conference

EAU 2021

Type

Peer-reviewed article

31 August 2021 12:28

Worse renal function after radical versus partial nephrectomy

Presented By

Prof. Francesco Trevisani, IRCCS Ospedale San Raffaele, Milan, Italy

Conference

EAU 2021

Type

Peer-reviewed article

31 August 2021 12:28

Best of EAU: Highlights on bladder cancer

Presented By

Prof. Morgan Rouprêt, Pitié-Salpêtrière Hospital, Paris, France

Conference

EAU 2021

Type

Peer-reviewed article

31 August 2021 12:26

ctDNA can guide adjuvant immunotherapy in muscle-invasive bladder cancer

Presented By

Prof. Jürgen Gschwend, Technical University Munich, Germany

Trial

Phase 3, IMvigor010, IMvigor011

Conference

EAU 2021

Type

Peer-reviewed article

31 August 2021 12:26

Durvalumab ± tremelimumab by cisplatin eligibility in metastatic urothelial carcinoma

Presented By

Prof. Thomas Powles, Barts Cancer Centre, London, UK

Trial

Phase 3, DANUBE

Conference

EAU 2021

Type

Peer-reviewed article

31 August 2021 12:26

Circulating tumour cells could aid in the decision to give neoadjuvant chemotherapy

Presented By

Dr Nick Beije, Erasmus Medical Center, Rotterdam, the Netherlands

Trial

CirGuidance

Type

Peer-reviewed article

31 August 2021 12:26

Best of EAU: New advances in testicular and penile cancer

Presented By

Prof. Maarten Albersen, UZ Leuven, Belgium

Conference

EAU 2021

Type

Peer-reviewed article

31 August 2021 12:23

Recommendations for the management of indeterminate small testis masses

Presented By

Mr Shafi Wardak, University College London Hospitals, UK

Conference

EAU 2021

Type

Peer-reviewed article

31 August 2021 12:23

Residual tumour resection in case of elevated markers

Presented By

Dr Yue Che, University of Düsseldorf, Germany

Conference

EAU 2021

Type

Peer-reviewed article

31 August 2021 12:23

EAU TV: Robotic surgery and advanced prostate cancer

Presented By

Prof. Maarten Albersen; Prof. Mottrie; Prof. Fizazi; Prof. Gillessen

Trial

VISION

Conference

EAU 2021

31 August 2021 12:15

EAU TV: The best on prostate cancer and incontinence & andrology

Presented By

Prof. Peter Albers; Prof. James N’Dow; Prof. Nicolas Mottet; Prof. Monique Roobol; Prof. Jens Sønksen; Prof. Francisco Cruz

Conference

EAU 2021

31 August 2021 12:15

Best of EAU: Updates on imaging and treatment of prostate cancer

Presented By

Prof. Alberto Briganti, IRCCS Ospedale San Raffaele, Milan, Italy

Trial

STHLM3MRI, TITAN

Conference

EAU 2021

Type

Peer-reviewed article

31 August 2021 12:15

Radiographic PFS benefit of adding abiraterone to ADT and docetaxel in mCSPC

Presented By

Prof. Karim Fizazi, University of Paris-Saclay, Villejuif, France

Trial

Phase 3, PEACE-1

Conference

EAU 2021

Type

Peer-reviewed article

31 August 2021 12:15

177Lu-PSMA-617: A new class of effective therapy

Presented By

Prof. Johann de Bono; Prof. Michael Hofman

Trial

VISION, TheraP

Conference

EAU 2021

Type

Peer-reviewed article

31 August 2021 12:15

Prophylactic treatments for recurrent urinary tract infections

Presented By

Prof. María Fernanda Lorenzo Gómez, University of Salamanca, Spain

Conference

EAU 2021

Type

Peer-reviewed article

31 August 2021 12:13

Failure of conservative management in emphysematous pyelonephritis

Presented By

Dr Ahmed Saadi, University of Tunis, Tunesia

Conference

EAU 2021

Type

Peer-reviewed article

31 August 2021 12:13

Antibiotic treatment of healthcare-associated infections

Presented By

Dr José Medina-Polo, Hospital Universitario 12 de Octubre, Madrid, Spain

Conference

EAU 2021

Type

Peer-reviewed article

31 August 2021 12:13

Best of EAU: The surgical armamentarium is evolving

Presented By

Prof. Jean-Nicolas Cornu, CHU Charles Nicolle, Rouen, France

Conference

EAU 2021

Type

Peer-reviewed article

31 August 2021 12:11

IPSS: Visual alternatives to aid comprehension and new risk prediction models

Presented By

Dr Florine Schlatmann; Prof. Stavros Gravas

Conference

EAU 2021

Type

Peer-reviewed article

31 August 2021 12:11

Letter from the Editor

Editor

Dr Stefan Rauh, Centre Hospitalier Emile Mayrisch, Esch, Luxembourg

Conference

ASCO GU 2021

24 March 2021 15:18

Researchers call for an overhaul of licensing and funding of anti-cancer drugs

Presented By

Dr David O’Reilly, Cork University Hospital, Ireland

Conference

ASCO GU 2021

24 March 2021 15:08

Exploring a new strategy for metastatic germ cell tumours

Presented By

Ms Shalini Subramaniam, NHMRC Clinical Trials Centre, University of Sydney, Australia

Trial

Phase 3, P3BEP

Conference

ASCO GU 2021

24 March 2021 15:08

Poorer outcomes in bladder cancer predicted by race/ethnicity and gender

Presented By

Dr Shaakir Hasan, New York Proton Centre, USA

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 15:03

Enfortumab vedotin as a promising treatment option for bladder cancer: phase 3 results

Presented By

Dr Thomas Powles, Barts Cancer Centre, UK

Trial

Phase 3, EV-301

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 15:03

Enfortumab vedotin as a promising treatment option for bladder cancer: phase 2 results

Presented By

Dr Arjun Vasant Balar, NYU Langone Medical Oncology, USA

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 15:02

New standard of care recommended for patients with upper tract urothelial cancer

Presented By

Dr Alison Birtle, Rosemere Cancer Centre, UK

Trial

Phase 3, POUT

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 15:02

Signature DNA alterations in subtypes of bladder cancer

Presented By

Dr Andrew Thomas Lenis, Memorial Sloan Kettering Cancer Centre, New York, USA

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 15:02

ACE inhibitors associated with superior responses in bladder cancer

Presented By

Dr Jonathan Thomas, Beth Israel Deaconess Medical Centre, Massachusetts, USA

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 15:02

Better allocation of research dollars needed

Presented By

Ms Jeenan Kaiser, University of Alberta, Canada

Conference

ASCO GU 2021

24 March 2021 15:02

Better prediction of favourable responses to immune checkpoint inhibitors in mUC

Presented By

Dr Marie Alt, Princess Margaret Cancer Centre, Canada

Conference

ASCO GU 2021

24 March 2021 15:02

New prediction model for brain metastasis in germ cell tumours

Presented By

Dr Ryan Ashkar, Indiana University Simon Comprehensive Cancer Centre, USA

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 14:58

Reduction in radiation exposure is possible in testicular seminoma surveillance

Presented By

Prof. Robert Huddart, Royal Marsden Hospital and Institute of Cancer Research, UK

Trial

Phase 3, TRISST

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 14:58

New therapeutic option for early metastatic seminoma

Principal Investigator

Prof. Siamak Daneshmand, University of Southern California, USA

Trial

Phase 2, SEMS

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 14:57

Superior clinical outcomes and QoL with nivolumab plus cabozantinib in RCC

Presented By

Prof. David Cella, Robert H. Lurie Comprehensive Cancer Centre, Northwestern University, Illinois, USA

Trial

Phase 3, CheckMate 9ER

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 14:53

Lenvatinib plus pembrolizumab prolongs survival in renal cell carcinoma

Presented By

Dr Robert Motzer, Memorial Sloan Kettering Cancer Centre, New York, USA

Trial

Phase 3, CLEAR

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 14:53

Inflammatory markers may guide treatment decisions in metastatic renal cell cancer

Presented By

Ms Vishwani Chauhan, University of Edinburgh, UK

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 14:53

Clinical trial exclusion criteria may lead to lack of evidence in real-world patients: how do the excluded fare?

Presented By

Dr Diana Maslov, Ochsner Health System, Louisiana, USA

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 14:53

Axitinib offers hope for improving renal cell cancer surgical outcomes

Presented By

Prof. Grant Stewart, University of Cambridge, UK

Trial

Phase 2, NAXIVA

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 14:53

Cabozantinib as possible new first-line therapy in translocation renal cell carcinoma

Presented By

Dr Jonathan Thouvenin, Institut de Cancerologie Strasbourg Europe, France

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 14:52

Predictors of oral anti-cancer agent utilisation in renal cell carcinoma

Presented By

Prof. Stephanie Wheeler, University of North Carolina, USA

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 14:52

Denosumab plus pembrolizumab in advanced clear cell renal cell carcinoma

Presented By

Dr Craig Gedye, Calvary Mater Newcastle, Australia

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 14:52

Prognosis of penile cancer associated with HPV status

Presented By

Dr Adithya Chennamadhavuni, University of Iowa, USA

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 14:50

Lu177 as a promising new therapy for metastatic prostate cancer

Presented By

Dr Michael Hofman, Peter MacCallum Cancer Centre, Australia

Trial

Phase 2, TheraP

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 14:49

Role of prostate cancer genomics is evolving

Presented By

Dr Ashley Ross, Feinberg School of Medicine, Northwestern University, Chicago, USA

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 14:49

Apalutamide prolongs progression-free survival in prostate cancer

Presented By

Dr Dana Rathkopf, Memorial Sloan Kettering Cancer Center, New York, USA

Trial

Phase 3, ACIS

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 14:49

Dose-intensified radiation therapy fails to provide better outcomes in prostate cancer

Presented By

Prof. Pirus Ghadjar, Charité Universitätsmedizin Berlin, Germany

Trial

Phase 3, SAKK 09/10

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 14:48

Intrinsic tumour biology may be predictive of treatment response in prostate cancer

Presented By

Prof. Felix Feng, University of California San Francisco, USA

Trial

Phase 3, SPARTAN

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 14:46

Final TITAN trial results favour use of apalutamide

Presented By

Dr Kim Chi, British Columbia Cancer and Vancouver Prostate Centre, Canada

Trial

Phase 3, TITAN

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 14:46

ASCO GU 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ASCO GU 2021

17 February 2021 13:28

Minimizing post-operative stress urinary incontinence after HoLEP: Our preliminary experience and short-term results of ‘’En Bloc’’ technique with early apical release

Presented By

Dr A. Tuccio, Careggi Hospital, University of Florence, Italy

Conference

EAU 2020

16 September 2020 16:28

Transperineal laser ablation of prostate

Presented By

Dr G.D. De Rienzo, Azienda Ospedaliera Policlinico di Bari, Italy

Conference

EAU 2020

16 September 2020 16:21

Beyond the limits of ultrasound: Three dimensional augmented reality robot assisted partial nephrectomy (3D AR-RAPN) for complex renal masses

Presented By

Prof. F. Porpiglia, Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Italy

Conference

EAU 2020

16 September 2020 15:55

Imaging guided surgery with augmented reality for robotic partial nephrectomy

Presented By

Prof. R. Schiavina, Sant'Orsola-Malpighi Hospital, Italy

Conference

EAU 2020

16 September 2020 15:49

Intra-operative cone-beam computed tomography for detecting residual stones in percutaneous nephrolithotomy

Presented By

Mr R.A. Kingma, University Medical Center Groningen, the Netherlands

Conference

EAU 2020

16 September 2020 15:42

The new adjustable artificial sphincter victo: Surgical technique and results after a follow-up of more than one year

Presented By

By Dr G. Ameli, Clinic of Korneuburg, Austria

Conference

EAU 2020

16 September 2020 15:23

Peyronie’s disease: surgical options

Presented By

Dr Juan Ignacio Martínez-Salamanca, University Hospital Puerta de Hierro Majadahonda, Spain

Conference

EAU 2020

Type

Peer-reviewed article

24 August 2020 14:20

Infertility and testis cancer risk: causal or association?

Presented By

Prof. Leendert Looijenga , Princess Máxima Center for Pediatric Oncology, the Netherlands

Conference

EAU 2020

Type

Peer-reviewed article

24 August 2020 14:15

32% more men complain of reduced sex drive in 2019 versus 2009

Presented By

Prof. Paolo Capogrosso, San Raffaele Hospital, Milan, Italy

Conference

EAU 2020

Type

Peer-reviewed article

24 August 2020 13:37

LUTS 2-year outcomes: aquablation versus TURP

Presented By

Dr Neil Barber, Frimley Health NHS Foundation Trust, UK

Trial

Phase 3, WATER

Conference

EAU 2020

Type

Peer-reviewed article

24 August 2020 11:33

HoLEP versus PVP in prospective randomised trial

Presented By

Dr Yan-Bo Chen, Shanghai Jiao Tong University, China

Conference

EAU 2020

Type

Peer-reviewed article

24 August 2020 11:30

LUTS in the neuro-urologic patient

Presented By

Dr Lysanne Campeau , McGill University, Canada

Conference

EAU 2020

Type

Peer-reviewed article

24 August 2020 11:20

Prostatectomy: R-LRPE better than LRPE for continence

Principal Investigator

Prof. Jens-Uwe Stolzenburg , University of Leipzig, Germany

Trial

LAP-01

Conference

EAU 2020

Type

Peer-reviewed article

21 August 2020 14:49

PSMA PET-CT staging is 27% more accurate

Principal Investigator

Prof. Michael Hofman, Peter MacCallum Cancer Centre, Australia

Trial

ProPSMA

Conference

EAU 2020

Type

Peer-reviewed article

21 August 2020 14:40

Docetaxel + hormonal therapy: improved prostate cancer PFS

Presented By

Dr Andreas Josefsson , Sahlgrenska University Hospital, Sweden

Trial

Phase 3, SPCG-14

Conference

EAU 2020

Type

Peer-reviewed article

21 August 2020 14:34

ARAMIS subgroup analysis: darolutamide benefits across PSADT groups

Principal Investigator

Prof. Martin Bögemann, University of Münster, Germany

Trial

Phase 3, ARAMIS

Conference

EAU 2020

Type

Peer-reviewed article

21 August 2020 13:42

Large patient-driven survey reveals QoL issues after prostate cancer treatment

Presented By

Mr André Deschamps , Europa Uomo, Belgium

Trial

EUPROMS

Conference

EAU 2020

Type

Peer-reviewed article

20 August 2020 13:05

Targeting steroid sulphatase in resistant prostate cancer cells

Presented By

Prof. Allen C. Gao , University of California Davis, USA

Conference

EAU 2020

Type

Peer-reviewed article

20 August 2020 13:00

Good tolerance of post-RP radiotherapy ± short-term ADT

Presented By

Dr Paul Sargos , Institut Bergonié, France

Trial

Phase 2, GETUG-AFU 22

Conference

EAU 2020

Type

Peer-reviewed article

20 August 2020 12:54

Reduced BCG frequency, faster NMIBC recurrence

Presented By

Prof. Marc-Oliver Grimm, University Hospital Jena, Germany

Trial

Phase 3, NIMBUS

Conference

EAU 2020

Type

Peer-reviewed article

20 August 2020 12:51

Nadofaragene firadenovec effective in BCG-unresponsive papillary NMIBC

Presented By

Dr Neal Shore, Carolina Urologic Research Center, USA

Conference

EAU 2020

Type

Peer-reviewed article

20 August 2020 12:44

Understanding MIBC biology for novel treatment options

Presented By

Prof. Yohann Loriot, Université Paris-Saclay, France

Trial

BLC2001; THOR; EV-301; EV-302; TROPHY-U-01; RANGE

Conference

EAU 2020

Type

Peer-reviewed article

20 August 2020 12:36

KEYNOTE-426: no QoL differences pembrolizumab + axitinib versus sunitinib

Presented By

Prof. Jens Bedke, University of Tübingen, Germany

Trial

Phase 3, KEYNOTE-426

Conference

EAU 2020

Type

Peer-reviewed article

20 August 2020 10:41

Debate: upfront cytoreductive nephrectomy or not?

Presented By

Prof. Axel Bex & Prof. Antonio Finelli

Trial

Phase 3, CARMENA; SURTIME

Conference

EAU 2020

Type

Peer-reviewed article

20 August 2020 09:29

Robotic-assisted partial nephrectomy: lower morbidity

Presented By

Dr Alessandro Larcher, Ospedale San Raffaele, Italy

Trial

IRON

Conference

EAU 2020

Type

Peer-reviewed article

20 August 2020 09:22

Pressure and temperature: do high-power lasers pose a threat?

Principal Investigator

Prof. Evangelos Liatsikos, University of Patras, Greece

Conference

EAU 2020

Type

Peer-reviewed article

20 August 2020 09:15

Radiation stewardship for patient and endourologist

Presented By

Prof. Andreas Skolarikos , University of Athens, Greece

Conference

EAU 2020

Type

Peer-reviewed article

20 August 2020 09:07

Letter from the Editor

Editor

Prof. Hendrik Van Poppel

Conference

EAU 2020

Type

Peer-reviewed article

20 August 2020 09:00

New lithotripter data: improved stone clearance

Presented By

Dr Oliver Wiseman , Cambridge University, UK

Conference

EAU 2020

Type

Peer-reviewed article

20 August 2020 09:00

New urosepsis data from the SERPENS study

Presented By

Dr Zafer Tandoğdu, University College London, UK

Trial

SERPENS

Conference

EAU 2020

Type

Peer-reviewed article

20 August 2020 08:44

EAU 2020 Highlights Podcast

Presented By

Dr Rachel GIles, Medicom

Conference

EAU 2020

20 August 2020 08:00

Barentsz Trial – Bi-parametric MRI versus multi-parametric MRI

Presented By

Prof. Jelle Barentsz, Prof. Jochen Walz, Prof. Arnaud Villers

Conference

EAU 2019

22 May 2019 11:49

Enzalutamide plus ADT improves outcomes for metastatic hormone-sensitive prostate cancer

Presented By

Prof. Antonio Alcaraz, Prof. Noel Clarke

Trial

Phase 3, ARCHES

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 23:59

Decision aids are too difficult for patients

Presented By

Dr Florine Schlatmann and Dr Michael van Balken, Rijnstate Hospital Arnhem, the Netherlands

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 23:55

Live surgery bladder tumour resection

Presented By

Prof. Alberto Breda, Fundació Puigvert, Spain

Conference

EAU 2019

21 May 2019 23:50

Letter from the Editor

Editor

Frank Van der Aa, University Hospital Leuven, Belgium

Conference

EAU 2019

21 May 2019 23:44

Live penile implant surgery

Presented By

Dr Sean Park, Stand Up Urology, South Korea

Conference

EAU 2019

21 May 2019 23:40

Largest safety study of its kind with atezolizumab in metastatic bladder cancer

Presented By

Prof. Axel Merseburger, Prof. Jens Bedke

Trial

Phase 3, SAUL, IMvigor211

Conference

EAU 2019

21 May 2019 23:38

Microdissection testicular sperm extraction (microTESE)

Presented By

Ranjith Ramasamy, University of Miami Miller School of Medicine, Florida, USA

Conference

EAU 2019

21 May 2019 23:30

HPV and penile cancer

Presented By

Dr Andrea Salonia, Prof. Stéphane Droupy, Dr Philippe Spiess

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 23:20

Focus on kidney: End of monotherapy

Presented By

Dr Ignacio Duran, University of Barcelona, Spain

Conference

EAU 2019

21 May 2019 23:15

Image guided robotic partial nephrectomy IGRAPN

Conference

EAU 2019

21 May 2019 23:10

Renal transplantation

Presented By

Dr Mireia Musquera, Dr Mark Sullivan

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 23:08

The Urodynamics for Prostate Surgery Trial

Presented By

Prof. Marcus Drake, Prof. Stavros Gravas, Prof. Ferdinando Fusco

Trial

UPSTREAM

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 23:04

Over-active bladder

Presented By

Dr Kurt McCammon, Dr Philip Toosz-Hobson, Prof. Martin Michel

Conference

EAU 2019

21 May 2019 22:59

Bladder cancer risk and early detection

Presented By

Dr Thibault De La Motte Rouge, Dr Wei Shen Tan, Dr Bas van Rhijn, Dr Francesco Soria

Trial

EDIFICE 6, DETECT 1

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 22:44

Male infertility/Premature ejaculation

Presented By

Dr Jonathan Ramsay, Prof. Maarten Albersen, Dr Cath Mercer

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 22:32

Prostate cancer active surveillance: Better patient risk stratification and use of imaging

Presented By

Dr Todd Morgan, Dr Vasilis Stavrinides, Dr Marco Bandini

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 22:03

Consensus treatment pathway for patients with limited pelvic lymph node involvement in otherwise localised bladder cancer

Presented By

Prof. Jürgen Gschwend, Prof. Sergio Bracarda

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 21:47

Testosterone replacement therapy: Safe and maybe even protective

Presented By

Prof. Thomas Ahlering, Dr Maxwell Towe, Ribeiro Morgado

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 21:36

Renal cell carcinoma

Trial

OpeRA

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 21:16

The role of pelvic lymph node dissection in prostate cancer: Extended vs standard

Presented By

Dr Karim Touijer, Dr Akshay Sood

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 21:10

When to use imaging and imaging-guided therapies

Presented By

Dr Lorenzo Bianchi, Dr Carlo Andrea Bravi

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 20:53

FGFR3 gene mutation: Favourable prognostic impact in bladder cancer

Presented By

Dr Laura Mertens, VU Amsterdam Medical Center, the Netherlands

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 20:52

Focus on treatment of erectile dysfunction and Peyronie’s disease

Presented By

Dr Uros Milenkovic, Dr Antonio Ruffo, Dr Amr Abdel Raheem

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 20:40

Bladder cancer in young patients

Presented By

Dr Roland Seiler, Prof. Morgan Rouprêt, Prof. Fiona Burkhard

Trial

IMvigor 210

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 19:55

Radioguided surgery is the future?

Presented By

Dr Sophie Knipper, University Hospital Hamburg-Eppendorf, Germany

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 19:54

Spanish study directly links surgical volume with mortality in bladder cancer patients undergoing cystectomy

Presented By

Dr Ana Guijarro Cascales, Hospital Universitario Fundacion Alcorcon, Spain

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 18:57

Cytoreductive radical prostatectomy: LoMP trial results

Trial

LoMP

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 18:24

Updated interim results of phase 2 trial of pembrolizumab for high-risk NMIBC unresponsive to BCG

Presented By

Prof. Ashish Kamat, MD Anderson Cancer Center, Houston, USA

Trial

KEYNOTE-057, KEYNOTE-676

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 17:01

Interview with EAU Secretary-General Prof. Chris Chapple

Expert

Prof. Chris Chapple, Sheffield, UK

Conference

EAU 2019

21 May 2019 13:47

Penile prosthesis implantation

Presented By

Dr Mahmoud Osman, Dr Mohamad Habous, Prof. Thomas Ahlering , Dr Frederico Dehò

Trial

PHOENIX

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 12:50

Minimally invasive surgical techniques must compete against pharmacotherapy in benign prostate hyperplasia (BPH)

Presented By

Prof. Damien Bolton, University of Melbourne, Australia

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 12:06

Office urology

Presented By

Dr Stefan Heansel, Franciscus Hospital Rotterdam, the Netherlands

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 12:01

Prostate cancer: What to expect the next 12 months

Trial

STAMPEDE, ENZAMET

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 10:27

Robot-assisted radical cystectomy or open radical cystectomy?

Presented By

Prof. Jens Bedke, Prof. Seth Lerner, Prof. James Catto

Trial

RAZOR, iROC

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 09:05

Letter from the Editor

Editor

Prof. dr. Frank Van der Aa, University Hospital Leuven, Belgium

Conference

EAU 2017

28 March 2017 12:46